Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist.
Coltamai L, Bucher M, Maillard MP, Shukla U, Bohidar N, Haskell L, Bertelsen K, Fedgchin M, Vogt B, Burnier M.
Coltamai L, et al. Among authors: vogt b.
Clin Pharmacol Ther. 2009 Feb;85(2):145-8. doi: 10.1038/clpt.2008.217. Epub 2008 Nov 5.
Clin Pharmacol Ther. 2009.
PMID: 18987622
Clinical Trial.
No abstract available.